Updated:
California Institute for Quantitative Biosciences
California Institute for Quantitative Biosciences (QB3) — a public-private research consortium linking UC campuses with industry across five U.S.
California Institute for Quantitative Biosciences
QB3 was established in 2000 as one of four California Institutes for Science and Innovation, a state-funded program to accelerate research-to-commercialization pipelines. The consortium brings together faculty and labs from UC San Francisco, UC Berkeley, and UC Santa Cruz, focusing on quantitative approaches to biology — including genomics, bioinformatics, and systems biology. Strategy is centered on accelerating life-science discoveries through computational methods, AI/ML-driven drug discovery, and biotech incubation. QB3 runs a network of incubators and shared laboratories that have supported over 100 startup companies. The consortium does not deploy third-party capital directly but facilitates industry partnerships and licensing for member universities. The institute maintains offices in Menlo Park, New York, Berkeley, Bala Cynwyd, Boston, San Francisco, and London. It operates QB3-Berkeley and QB3 at the Mission Bay campus in San Francisco. No recent operational events were publicly documented in the last 24 months. QB3's structural differentiator is its government-university hybrid model — a state-chartered institute that functions as a deal-flow funnel for California's largest public research universities without raising or managing a commingled investment fund.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
New York, NY, United States · Berkeley, CA, United States · Bala Cynwyd, PA, United States · Boston, MA, United States · San Francisco, CA, United States · London, United Kingdom
Sector focus
Frequently asked questions
Is QB3 an investment fund or a research institute?
QB3 is a public-private research consortium, not an investment fund. It does not manage capital for third parties. Its role is to facilitate commercialization of university research through incubators, industry partnerships, and licensing agreements (per the University of California, 2024).
How does QB3 support startups?
QB3 provides wet-lab incubator space, access to shared equipment, and industry mentorship for biotech startups. The institute has helped launch over 100 companies since its founding (per QB3 official communications). It does not provide direct venture capital but connects startups with external investors.
Which universities are part of QB3?
QB3 is a consortium of three University of California campuses: UC San Francisco, UC Berkeley, and UC Santa Cruz (per the California Institutes for Science and Innovation program description). Each campus contributes faculty, labs, and research infrastructure.
What scientific disciplines does QB3 focus on?
The consortium specializes in quantitative biology — integrating computational modeling, genomics, bioinformatics, and AI/ML into life-sciences research (per QB3 historical mission statements). It prioritizes fields like drug discovery, synthetic biology, and systems biology.
Does QB3 license technologies directly?
QB3 facilitates technology licensing through the University of California's Office of Technology Licensing. The consortium itself does not hold patents or negotiate licenses but provides a pipeline for member university inventions to reach commercialization.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: